Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma

Completed · Phase 1/Phase 2

Conditions studied: Sarcoma

In brief

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as SU5416 may stop the growth of cancer by stopping blood flow to the tumor. It is not yet known if radiation therapy is more effective with or without SU5416 in treating soft tissue sarcoma. PURPOSE: Phase I/II trial to compare the effectiveness of radiation therapy with or without SU5416 in treating patients who have stage IB or stage IIA soft tissue sarcoma.

Key facts

Study ID
NCT00023725
Run by
Radiation Therapy Oncology Group
Starts
2001-08-01
Expected to finish
2003-10-01
Last updated by the study team
2013-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.